​

CASI Pharmaceuticals (CASI) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

CASI Stock Forecast

CASI Pharmaceuticals (CASI) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 279.75% increase from the last price of $1.58.

$1 $2 $3 $4 $5 $6 $7 $8 High: $6 Avg: $6 Low: $6 Last Closed Price: $1.58

CASI Stock Rating

CASI Pharmaceuticals stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 6 Strong Sell Sell Hold Buy Strong Buy

CASI Price Target Upside V Benchmarks

TypeNameUpside
StockCASI Pharmaceuticals279.75%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.58$1.58$1.58
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 251----1
Sep, 251----1
Aug, 251----1
Jul, 251----1
Jun, 251----1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 15, 2024Sean LeeH.C. Wainwright$6.00$3.2684.05%279.75%
Aug 15, 2022H.C. Wainwright$12.00$4.02198.51%659.49%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 15, 2024H.C. WainwrightBuyBuyhold
Nov 16, 2022BTIGBuyBuyhold
Jun 03, 2022BTIGBuyBuyhold

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-5.66$-2.78$-2.89$-2.02-----
Avg Forecast$-3.56$-3.03$-1.14$-1.93$-2.56$-2.13$-1.75$-1.62$-1.36
High Forecast$-3.56$-3.03$-1.14$-1.93$-2.56$-2.13$-1.75$-1.62$-1.36
Low Forecast$-3.56$-3.03$-1.14$-1.93$-2.56$-2.13$-1.75$-1.62$-1.36
Surprise %58.99%-8.25%153.51%4.66%-----

Revenue Forecast

$10M $30M $50M $70M $90M $110M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$15.14M$30.17M$43.11M$33.88M-----
Avg Forecast$14.69M$30.08M$42.08M$36.42M$19.80M$46.48M$70.35M$89.46M$108.07M
High Forecast$14.69M$30.08M$42.08M$36.42M$19.80M$46.48M$70.35M$89.46M$108.07M
Low Forecast$14.69M$30.08M$42.08M$36.42M$19.80M$46.48M$70.35M$89.46M$108.07M
Surprise %3.05%0.29%2.44%-6.97%-----

Net Income Forecast

$-65M $-55M $-45M $-35M $-25M $-15M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-62.57M$-37.77M$-39.41M$-26.94M-----
Avg Forecast$-47.52M$-40.53M$-33.37M$-26.96M$-34.20M$-28.46M$-23.38M$-21.64M$-18.17M
High Forecast$-47.52M$-40.53M$-26.69M$-21.57M$-34.20M$-28.46M$-23.38M$-21.64M$-18.17M
Low Forecast$-47.52M$-40.53M$-40.04M$-32.35M$-34.20M$-28.46M$-23.38M$-21.64M$-18.17M
Surprise %31.66%-6.80%18.12%-0.08%-----

CASI Forecast FAQ

Is CASI Pharmaceuticals stock a buy?

CASI Pharmaceuticals stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that CASI Pharmaceuticals is a favorable investment for most analysts.

What is CASI Pharmaceuticals's price target?

CASI Pharmaceuticals's price target, set by 6 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 279.75% change from the previous closing price of $1.58.

How does CASI Pharmaceuticals stock forecast compare to its benchmarks?

CASI Pharmaceuticals's stock forecast shows a 279.75% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for CASI Pharmaceuticals over the past three months?

  • October 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is CASI Pharmaceuticals’s EPS forecast?

CASI Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2024 is $-2.56, marking a 26.73% increase from the reported $-2.02 in 2023. Estimates for the following years are $-2.13 in 2025, $-1.75 in 2026, $-1.62 in 2027, and $-1.36 in 2028.

What is CASI Pharmaceuticals’s revenue forecast?

CASI Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2024 is $19.8M, reflecting a -41.57% decrease from the reported $33.88M in 2023. The forecast for 2025 is $46.48M, followed by $70.35M for 2026, $89.46M for 2027, and $108.07M for 2028.

What is CASI Pharmaceuticals’s net income forecast?

CASI Pharmaceuticals's net income forecast for the fiscal year ending in December 2024 stands at $-34.202M, representing an 26.97% increase from the reported $-26.938M in 2023. Projections indicate $-28.457M in 2025, $-23.38M in 2026, $-21.644M in 2027, and $-18.17M in 2028.